Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment

The underlying mechanisms leading to antiestrogen resistance in estrogen-receptor α (ER)-positive breast cancer is still poorly understood. The aim of this study was therefore to identify biomarkers and novel treatments for antiestrogen resistant breast cancer. We performed a kinase inhibitor screen...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Sarah L., Laenkholm, Anne-Vibeke, Duun-Henriksen, Anne Katrine, Bak, Martin, Lykkesfeldt, Anne E., Kirkegaard, Tove
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338193/
https://www.ncbi.nlm.nih.gov/pubmed/25706943
http://dx.doi.org/10.1371/journal.pone.0118346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338193/
https://www.ncbi.nlm.nih.gov/pubmed/25706943
http://dx.doi.org/10.1371/journal.pone.0118346

Ejemplares similares